Skip to main content
OpenTrials

Clinical trial condition

Triple Negative Breast Neoplasms

Explore clinical trials studying Triple Negative Breast Neoplasms. Study availability and eligibility vary by location and protocol.

819 public trials 296 recruiting studies
Refine in advanced search Browse all conditions

Triple Negative Breast Neoplasms trial results

Completed

Study of B013 and Nab-Paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer

NCT05555706

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • Affiliated Cancer Hospital, Sun Yat-sen University Guangzhou, Guangdong, China
  • Guangxi Medical University Cancer Hospital Nanning, Guangxi, China
  • Hainan cancer Hospital Haikou, Hainan, China
  • The First Affiliated Hospital of henan University of Science and Technoloy Luoyang, Henan, China
View all 13 locations
View Trial Details
Completed

Study of XB002 in Subjects With Solid Tumors (JEWEL-101)

NCT04925284

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +57 more
Locations
  • Exelixis Clinical Site #48 Birmingham, Alabama, United States
  • Exelixis Clinical Site #20 Tucson, Arizona, United States
  • Exelixis Clinical Site#95 Tucson, Arizona, United States
  • Exelixis Clinical Site#58 Little Rock, Arkansas, United States
View all 95 locations
View Trial Details
Completed

Palbociclib and Binimetinib in Advanced Triple Negative Breast Cancer

NCT04494958

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • Hospital Universitari Arnau de Vilanova de Lleida Lleida, Spain
  • Hospìtal Universitario de la Princesa Madrid, Spain
  • Hospital Ramon y Cajal Madrid, Spain
  • Hospital Clínico San Carlos Madrid, Spain
View Trial Details
Completed

PAKT: AZD5363 in Combination With Paclitaxel in Triple-Negative Advanced or Metastatic Breast Cancer

NCT02423603

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +9 more
Locations
  • ICO René Gauducheau Nantes, France
  • Centre André-lacassagne Nice, France
  • Centre Hospitalier Prive Saint-Gregoire Saint-Grégoire, France
  • Institute of Clinical Oncology Tbilisi, Georgia
View all 46 locations
View Trial Details
Completed

Study of the Efficacy, Safety and Pharmacokinetics of Pamiparib (BGB-290) in Participants With Advanced Solid Tumors

NCT03333915

Conditions
Advanced High-grade Ovarian Cancer, Breast Diseases, Breast Neoplasms, +6 more
Locations
  • Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Henan Cancer Hospital Zhengzhou, Henan, China
  • Hunan Cancer Hospital Changsha, Hunan, China
View Trial Details
Completed

COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.

NCT03667716

Conditions
Adnexal Diseases, Advanced Cancer, Breast Cancer, +44 more
Locations
  • University of California Los Angeles (UCLA). Los Angeles, California, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Completed

CAB-ROR2-ADC Safety and Efficacy Study in Patients With TNBC or Head & Neck Cancer (Ph1) and NSCLC or Melanoma (Ph2)

NCT03504488

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +24 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • City of Hope - Duarte Duarte, California, United States
  • University of California, San Diego (UCSD) - Moores Cancer Center La Jolla, California, United States
  • California Research Institute Los Angeles, California, United States
View all 59 locations
View Trial Details

Related conditions